Table 1 Metastatic patient characteristics

From: Autoantibodies to endostatin in patients with breast cancer: correlation to endostatin levels and clinical outcome

Characteristics

No. of patients

%

Entered on study

59

100

Age (years)

 Median

54

 

 Range

26–83

 

PS

 0–1

41

69.5

 2–4

18

30.5

Receptor status (four missing values)

 ER positive

39

71

 ER negative

16

29

Adjuvant chemotherapy

 Received

28

47.5

 Not received

31

52.5

Prior chemotherapy for metastatic disease

 Received

41

69.5

 Not received

18

30.5

Disease-free interval (months)

 <24

27

46

 >24

32

54

Metastatic site

 Liver

36

61

 Lung

27

46

 One or two

34

58

 Three or more

25

42

Lymphocyte count (106cells l−1)

 Median

905

 

 Range

100–2700